accountJapanese drugmaker, broadening its reach in emerging markets and adding a remedy for smokers' cough to its portfolio. Asia's largest pharmaceutical company will pay cash for Zurich-based Nycomed, which is controlled by Nordic Capital and Credit Suisse...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Takeda Pharmaceutical to buy out Swiss-firm Nycomed for ����9.6 billion
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account